Hoping to continue sales of key drugs Synap Forte, Lentogesic and Doxyfene in spite of concerns.
The Medicines Control Council (MCC) has cancelled the registration of all products containing the painkiller dextropropoxyphene (DPP) over safety concerns, but Adcock Ingram is appealing its decision. Read the article.
